ACM
WGS icon

Aster Capital Management’s GeneDx Holdings WGS Stock Holding History

Aster Capital Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49
Closed -$6.37K – 1368
2025
Q4 		$6.37K Buy
+49
New +$6.72K ﹤0.01% 833
2025
Q2 		– Sell
-11
Closed -$1.13K – 1629
2025
Q1 		$1.13K Buy
11
+8
+267% +$694 ﹤0.01% 1186
2024
Q4 		$231 Sell
3
-43
-93% -$3K ﹤0.01% 1056
2024
Q3 		$1.95K Buy
+46
New +$1.55K ﹤0.01% 978

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Aster Capital Management's WGS Position: Q1 2026 in Review

Aster Capital Management sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 49 shares — an estimated $6.37K sold.

Aster Capital Management first reported a position in WGS in Q3 2024 and held it in 4 quarters. The position peaked at $6.37K in Q4 2025. 241 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Aster Capital Management reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Aster Capital Management sold 49 GeneDx Holdings shares in Q1 2026, an estimated $6.37K.
  • Aster Capital Management first reported a position in GeneDx Holdings in Q3 2024 and held it in 4 quarters.
  • Aster Capital Management's GeneDx Holdings position peaked at $6.37K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.